Modulation of CD4+ and CD8+ tumor infiltrating lymphocytes by a fraction isolated from shark cartilage: Shark cartilage modulates anti-tumor immunity

International Immunopharmacology

Volumn 3, Issue 7, 2003, Pages 921-926

  Feyzi, Reza ^a   Hassan, Zuhair M ^a   Mostafaie, Ali ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

CD4 CD8 ratio; CD4+ TIL; CD8+ TIL; Delayed type hypersensitivity; Shark cartilage

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FISH PROTEIN; IMMUNOSTIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CELL ISOLATION; CELLULAR IMMUNITY; CHROMATOGRAPHY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTIC INFILTRATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PERITONEUM; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; SHARK; SKIN TEST; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

EID: 0038180635     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00255-2     Document Type: Article

References (24)

1. Wilson J.L. Shark cartilage: a review of background literature and research. Townsend Lett. Dr. 133:1994;864-872.
2. Lane I.W., Comac L. Sharks still don't get cancer. 1996;Avery, New York.
3. Lee A., Langer R. Shark cartilage contains inhibitors of tumor angiogenesis. Science. 221:1983;1185-1187.
4. Oikawa T., Ashino-Fuse H., Shimamura M., Koide U., Iwaguchi T. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis. Cancer Lett. 51:1990;181-186.
5. Sheu J.R., Fu C.C., Tsai M.L., Chung W.J. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities. Anticancer Res. 18:1998;4435-4441.
6. Dupont E, Brazeau P, Juneau C, Maes DH, Marenus K. Methods of using extracts of shark cartilage. United States Patent. 2000;USP No:6,028,118.
7. Chen J.S., Chang C.M., Wu J.C., Wang S.M. Shark cartilage extract interferes with cell adhesion and induces reorganization of focal adhesions in cultured endothelial cells. J. Cell Biochem. 78:2000;417-428.
8. Liang J.H., Wong K.P. The characterization of angiogenesis inhibitor from shark cartilage. Adv. Exp. Med. Biol. 476:2000;209-223.
9. Bolis S., Handley C.J., Comper W.D. Passive loss of proteoglycan from articular cartilage explants. Biochim. Biophys. Acta. 993:1989;157-167.
10. Mantle T.J., Noone P. Chromatofocusing. Doonan S. Purification protocols. Methods in Molecular Biology. vol. 59:1996;249-255 Humana Press, Totowa, NJ.
11. Chromatofocusing: principles and methods. Pharmacia technical booklets.
12. Gel filtration: principles and methods. Pharmacia technical booklets.
13. Walker J.M. SDS polyacrylamide gel electrophoresis of proteins. Walker J.M. The protein protocols handbook. 1996;Humana Press, Totowa, NJ.
14. Ebtekar M., Hassan Z.M. Effect of immunomodulators pyrimethamine and cimetidine on immunosuppression induced by sulfur mustard in mice. Int. J. Immunopharmacol. 15:1993;533-541.
15. Lal R.B., Edison L.J., Chused T.M. Fixation and long-term storage of human lymphocytes for surface marker analysis by flow cytometry. Cytometry. 9:1988;213-219.
16. Lane IW. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage. United States Patent. 1991;USP No:5,075,112.
17. O'Hara C.F., Wong Cultured shark chondrocytes secrete an angiogenesis inhibitor. In Vitro Cell. Dev. Biol. 32:1996;57A.
18. Schinitsky M. Anti-inflamatory composition. United States Patent. 1984;USP No:4,473,551.
19. Descotes J. An introduction to immunotoxicology. 1st ed. 1999;Taylor & Francis.
20. Black C.A. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5(1):2000;7-11.
21. 8 ratio during prolonged four-drug chemotherapy plus interferon treatment for metastatic melanoma. J. Immunother. 15(1):1994;67-73.
22. Bernengo M.G.et al. The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up. Cancer. 52(10):1983;1841-1848.
23. Devita V.T. Biologic therapy of cancer. 1998;JB Lippincott, Philadelphia.
24. Griffioen A.W., Tromp S.C., Hillen H.F. Angiogenesis modulates the tumor immune response. Int. J. Exp. Path. 79:1998;363-368.